Anthony Francis Massaro, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromuscular Blocking Agents | 3 | 2023 | 130 | 0.600 |
Why?
|
| Intensive Care Units | 9 | 2020 | 3679 | 0.550 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2016 | 274 | 0.440 |
Why?
|
| Respiration, Artificial | 6 | 2023 | 2566 | 0.400 |
Why?
|
| Length of Stay | 5 | 2019 | 6294 | 0.380 |
Why?
|
| Nitric Oxide | 8 | 2002 | 2128 | 0.340 |
Why?
|
| Infection Control | 1 | 2016 | 962 | 0.330 |
Why?
|
| Respiration | 5 | 2016 | 1645 | 0.300 |
Why?
|
| Communication | 6 | 2017 | 3728 | 0.280 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3527 | 0.260 |
Why?
|
| Patient Participation | 4 | 2017 | 1445 | 0.230 |
Why?
|
| Sepsis | 4 | 2018 | 2589 | 0.210 |
Why?
|
| Hospital Mortality | 5 | 2019 | 5310 | 0.210 |
Why?
|
| Patient Care Planning | 5 | 2017 | 921 | 0.200 |
Why?
|
| Professional-Family Relations | 2 | 2017 | 481 | 0.190 |
Why?
|
| Neuromuscular Blockade | 1 | 2022 | 146 | 0.190 |
Why?
|
| Patient Care Team | 5 | 2017 | 2527 | 0.180 |
Why?
|
| Quality Indicators, Health Care | 3 | 2018 | 1831 | 0.170 |
Why?
|
| Asthma | 7 | 2021 | 5955 | 0.170 |
Why?
|
| Critical Care | 5 | 2023 | 2640 | 0.170 |
Why?
|
| Mental Disorders | 1 | 2018 | 6587 | 0.160 |
Why?
|
| Behavior | 1 | 2021 | 560 | 0.160 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 408 | 0.140 |
Why?
|
| Patient Preference | 2 | 2017 | 886 | 0.140 |
Why?
|
| Thorax | 1 | 2019 | 547 | 0.140 |
Why?
|
| Anesthetics | 1 | 2022 | 538 | 0.130 |
Why?
|
| Respiratory Therapy | 1 | 2016 | 132 | 0.130 |
Why?
|
| Oral Hygiene | 1 | 2016 | 125 | 0.130 |
Why?
|
| Critical Illness | 2 | 2019 | 2665 | 0.130 |
Why?
|
| Metabolomics | 2 | 2014 | 1467 | 0.130 |
Why?
|
| Blood Circulation | 1 | 1996 | 251 | 0.130 |
Why?
|
| Environment | 1 | 2021 | 1115 | 0.130 |
Why?
|
| Ulcer | 1 | 2016 | 209 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 2016 | 162 | 0.130 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2016 | 250 | 0.120 |
Why?
|
| Patient Positioning | 1 | 2016 | 322 | 0.120 |
Why?
|
| Computers, Handheld | 1 | 2015 | 208 | 0.120 |
Why?
|
| Respiratory Insufficiency | 2 | 2020 | 1199 | 0.110 |
Why?
|
| Long-Term Care | 1 | 2017 | 607 | 0.110 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2016 | 609 | 0.110 |
Why?
|
| Critical Pathways | 1 | 2016 | 475 | 0.100 |
Why?
|
| Bronchi | 1 | 1996 | 840 | 0.100 |
Why?
|
| Life Support Systems | 1 | 2010 | 11 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2016 | 638 | 0.100 |
Why?
|
| Physician-Patient Relations | 2 | 2010 | 3215 | 0.100 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1990 | 906 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2017 | 1426 | 0.090 |
Why?
|
| Anesthesia | 1 | 2022 | 1548 | 0.090 |
Why?
|
| Breath Tests | 2 | 2002 | 276 | 0.090 |
Why?
|
| Patient-Centered Care | 2 | 2017 | 1436 | 0.090 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 133 | 0.090 |
Why?
|
| Thromboembolism | 1 | 2016 | 983 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 2623 | 0.090 |
Why?
|
| Cross Infection | 1 | 2018 | 1413 | 0.080 |
Why?
|
| Family | 2 | 2017 | 3144 | 0.080 |
Why?
|
| Inpatients | 2 | 2017 | 2495 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2013 | 814 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1158 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 378 | 0.080 |
Why?
|
| Caregivers | 2 | 2017 | 2074 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2266 | 0.080 |
Why?
|
| Bacteremia | 1 | 2014 | 962 | 0.080 |
Why?
|
| Internet | 2 | 2017 | 3062 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 493 | 0.070 |
Why?
|
| Quality Improvement | 3 | 2017 | 3738 | 0.070 |
Why?
|
| Male | 27 | 2021 | 349538 | 0.070 |
Why?
|
| Delirium | 1 | 2018 | 1608 | 0.070 |
Why?
|
| Middle Aged | 16 | 2020 | 213127 | 0.070 |
Why?
|
| Female | 29 | 2021 | 379592 | 0.070 |
Why?
|
| Humans | 41 | 2023 | 742088 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1995 | 2107 | 0.070 |
Why?
|
| Cohort Studies | 6 | 2018 | 40450 | 0.070 |
Why?
|
| Sleep | 1 | 2021 | 4604 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 747 | 0.070 |
Why?
|
| Interviews as Topic | 3 | 2017 | 2536 | 0.060 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4440 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 1990 | 1274 | 0.060 |
Why?
|
| Massachusetts | 2 | 2016 | 8662 | 0.060 |
Why?
|
| Aged | 16 | 2022 | 162944 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4554 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1990 | 2524 | 0.060 |
Why?
|
| Health Personnel | 1 | 2017 | 3210 | 0.060 |
Why?
|
| Hospitalization | 3 | 2022 | 10232 | 0.060 |
Why?
|
| Interleukin-2 | 5 | 1990 | 1887 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1737 | 0.050 |
Why?
|
| Lymphocyte Activation | 3 | 1990 | 5519 | 0.050 |
Why?
|
| Forced Expiratory Volume | 3 | 1998 | 1741 | 0.050 |
Why?
|
| APACHE | 2 | 2019 | 277 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2017 | 4369 | 0.050 |
Why?
|
| Bronchial Provocation Tests | 2 | 2000 | 227 | 0.050 |
Why?
|
| Adult | 17 | 2023 | 213712 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2018 | 53187 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3584 | 0.050 |
Why?
|
| Paralysis | 1 | 2022 | 249 | 0.050 |
Why?
|
| Pharmacists | 1 | 2023 | 240 | 0.050 |
Why?
|
| Leukotriene E4 | 1 | 2000 | 79 | 0.050 |
Why?
|
| Heart Arrest | 1 | 2010 | 1469 | 0.050 |
Why?
|
| Methacholine Chloride | 1 | 2000 | 233 | 0.050 |
Why?
|
| Early Diagnosis | 2 | 2016 | 1184 | 0.050 |
Why?
|
| Proteomics | 1 | 2013 | 3618 | 0.050 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 15530 | 0.050 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 1503 | 0.040 |
Why?
|
| Exercise | 1 | 1996 | 5611 | 0.040 |
Why?
|
| Pulmonary Circulation | 1 | 2002 | 739 | 0.040 |
Why?
|
| Bronchodilator Agents | 1 | 2002 | 502 | 0.040 |
Why?
|
| Spirometry | 2 | 2000 | 862 | 0.040 |
Why?
|
| Terminal Care | 1 | 2010 | 1688 | 0.040 |
Why?
|
| Qualitative Research | 2 | 2017 | 2680 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 77098 | 0.040 |
Why?
|
| Cytokines | 1 | 2012 | 7317 | 0.040 |
Why?
|
| Medical Audit | 1 | 2018 | 467 | 0.040 |
Why?
|
| Tracheotomy | 1 | 2017 | 166 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1990 | 9274 | 0.030 |
Why?
|
| Bronchoscopes | 1 | 1996 | 62 | 0.030 |
Why?
|
| Beclomethasone | 1 | 1995 | 38 | 0.030 |
Why?
|
| Air | 1 | 1996 | 181 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 12730 | 0.030 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 1995 | 141 | 0.030 |
Why?
|
| Triamcinolone | 1 | 1995 | 68 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2017 | 438 | 0.030 |
Why?
|
| Computer Security | 1 | 2017 | 263 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2615 | 0.030 |
Why?
|
| Inservice Training | 1 | 2017 | 392 | 0.030 |
Why?
|
| Nursing Informatics | 1 | 2014 | 42 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 1996 | 289 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 2253 | 0.030 |
Why?
|
| Airway Obstruction | 2 | 1998 | 663 | 0.030 |
Why?
|
| Hospitals | 2 | 2018 | 3937 | 0.030 |
Why?
|
| Access to Information | 1 | 2017 | 320 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1995 | 388 | 0.030 |
Why?
|
| Disinfection | 1 | 2015 | 191 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2017 | 510 | 0.030 |
Why?
|
| Nasopharynx | 1 | 1996 | 379 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 1996 | 675 | 0.030 |
Why?
|
| Macaca | 1 | 2014 | 440 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 57683 | 0.030 |
Why?
|
| Pandemics | 2 | 2023 | 8328 | 0.030 |
Why?
|
| Lung | 2 | 2019 | 9826 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 1990 | 10163 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 1320 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2002 | 4197 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 736 | 0.030 |
Why?
|
| United States | 4 | 2018 | 69693 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 223 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21719 | 0.020 |
Why?
|
| Palliative Care | 2 | 2003 | 3478 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3199 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 1008 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2012 | 248 | 0.020 |
Why?
|
| Prednisone | 1 | 1995 | 1567 | 0.020 |
Why?
|
| Checklist | 1 | 2017 | 830 | 0.020 |
Why?
|
| Trachea | 1 | 1996 | 1075 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 766 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 1989 | 42 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1990 | 1368 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 766 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3766 | 0.020 |
Why?
|
| Emergencies | 1 | 1995 | 1164 | 0.020 |
Why?
|
| Vital Capacity | 2 | 2002 | 922 | 0.020 |
Why?
|
| Medical Informatics | 1 | 2015 | 742 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1996 | 1357 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2010 | 401 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2450 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 7276 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2211 | 0.020 |
Why?
|
| Ibuprofen | 1 | 1989 | 235 | 0.020 |
Why?
|
| Neoplasms | 4 | 2010 | 21596 | 0.020 |
Why?
|
| Hospices | 1 | 2010 | 264 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 1175 | 0.020 |
Why?
|
| Time Factors | 3 | 2018 | 40054 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 712 | 0.020 |
Why?
|
| Coma | 1 | 2010 | 475 | 0.020 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 1162 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 500 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1988 | 625 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3391 | 0.020 |
Why?
|
| Acute Disease | 1 | 1995 | 7141 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2010 | 950 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1459 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12242 | 0.020 |
Why?
|
| Oxygen | 1 | 1996 | 4169 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18006 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2010 | 1183 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8297 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2003 | 39004 | 0.010 |
Why?
|
| Inflammation | 2 | 2020 | 10578 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7770 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1989 | 1000 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1992 | 1255 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3839 | 0.010 |
Why?
|
| Decision Making | 1 | 2017 | 3869 | 0.010 |
Why?
|
| Killer Cells, Natural | 2 | 1989 | 2133 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 974 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2002 | 74 | 0.010 |
Why?
|
| Anxiety | 1 | 2017 | 4279 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9144 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2017 | 4229 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1989 | 4839 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 2002 | 377 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7153 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2012 | 2956 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19862 | 0.010 |
Why?
|
| Plethysmography | 1 | 2000 | 180 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29010 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2002 | 981 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 1990 | 19223 | 0.010 |
Why?
|
| Airway Resistance | 1 | 2000 | 404 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 9735 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7645 | 0.010 |
Why?
|
| Case Management | 1 | 2000 | 286 | 0.010 |
Why?
|
| Maximal Voluntary Ventilation | 1 | 1998 | 13 | 0.010 |
Why?
|
| Heart Failure | 1 | 2002 | 10856 | 0.010 |
Why?
|
| Sputum | 1 | 2000 | 474 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4214 | 0.010 |
Why?
|
| Smoking | 1 | 1995 | 8969 | 0.010 |
Why?
|
| Hyperventilation | 1 | 1998 | 81 | 0.010 |
Why?
|
| Phenotype | 3 | 1990 | 16331 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1998 | 143 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 3 | 1992 | 21821 | 0.010 |
Why?
|
| Animals | 5 | 2014 | 168561 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2000 | 1104 | 0.010 |
Why?
|
| Bronchoconstriction | 1 | 1998 | 141 | 0.010 |
Why?
|
| Mice | 4 | 2012 | 81045 | 0.010 |
Why?
|
| Cell Count | 1 | 2000 | 1831 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12773 | 0.010 |
Why?
|
| Eosinophils | 1 | 2000 | 953 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 56350 | 0.010 |
Why?
|
| Recombinant Proteins | 3 | 1990 | 6608 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1998 | 774 | 0.010 |
Why?
|
| ROC Curve | 1 | 2002 | 3528 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2000 | 10248 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2002 | 1911 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1998 | 1141 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 62966 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 13853 | 0.010 |
Why?
|
| Health Services Research | 1 | 2000 | 1834 | 0.010 |
Why?
|
| Steroids | 1 | 1998 | 931 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 72145 | 0.010 |
Why?
|
| Allergens | 1 | 1998 | 1314 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1676 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 1992 | 13019 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6365 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1998 | 1093 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1990 | 375 | 0.000 |
Why?
|
| Odds Ratio | 1 | 2000 | 9846 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1992 | 2085 | 0.000 |
Why?
|
| Boston | 1 | 2000 | 9305 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14720 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15056 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12344 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13403 | 0.000 |
Why?
|
| Prevalence | 1 | 2002 | 15194 | 0.000 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1989 | 1835 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1989 | 2614 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1992 | 8621 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1990 | 4414 | 0.000 |
Why?
|